Discretionary Denial By Patent Board Won't Be Debated At High Court
WASHINGTON, D.C. — A challenge by a pharmaceutical company to an August 2019 determination by the Federal Circuit U.S. Court of Appeals that it lacks jurisdiction over allegations that the Patent...To view the full article, register now.
Already a subscriber? Click here to view full article